Detail publikace

Nanocarriers for anticancer drugs - New trends in nanomedicine

DRBOHLAVOVÁ, J. CHOMOUCKÁ, J. ADAM, V. VACULOVIČOVÁ, M. HUBÁLEK, J. KIZEK, R.

Originální název

Nanocarriers for anticancer drugs - New trends in nanomedicine

Typ

článek v časopise - ostatní, Jost

Jazyk

angličtina

Originální abstrakt

This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy summarizing advantages and disadvantages of each approach. Particularly, we aim our attention at polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles and carbon nanotubes. Further, we briefly focus on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin and geldanamycin) and to the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility

Klíčová slova

Nanotechnologies; Nanoparticles; Gene Therapy; Anticancer drugs; Drug carriers; Cancer; Cytostatic; Targeted therapy.

Autoři

DRBOHLAVOVÁ, J.; CHOMOUCKÁ, J.; ADAM, V.; VACULOVIČOVÁ, M.; HUBÁLEK, J.; KIZEK, R.

Rok RIV

2013

Vydáno

13. 5. 2013

Nakladatel

Bentham Science

Místo

Sharjah, U. A. E.

ISSN

1389-2002

Periodikum

CURRENT DRUG METABOLISM

Ročník

14

Číslo

5

Stát

Stát Spojené arabské emiráty

Strany od

547

Strany do

564

Strany počet

18

BibTex

@article{BUT75687,
  author="Jana {Drbohlavová} and Jana {Pekárková} and Vojtěch {Adam} and Markéta {Vaculovičová} and Jaromír {Hubálek} and René {Kizek}",
  title="Nanocarriers for anticancer drugs - New trends in nanomedicine",
  journal="CURRENT DRUG METABOLISM",
  year="2013",
  volume="14",
  number="5",
  pages="547--564",
  doi="10.2174/1389200211314050005",
  issn="1389-2002"
}